CORPORATE RESPONSIBILITY AT RELX, 2021 HIGHLIGHTS
In 2021, RELX continued to build on our strong corporate responsibility (CR) performance during the year, further improving on our key internal metrics and extending the scope of our unique contributions. This article is linked to SDGs 1,3,10,11,12,13 and 16, in line with RELX's areas of expertise.
Elsevier,

International Journal of Clinical and Health Psychology,
Volume 23, Issue 3,
2023,
100363

This study underwrites the pivotal role of voluntary work in reducing the impact of symptoms of stress on the development of depressive symptoms and the likelihood of being prescribed an antidepressant.
These dashboards present data from the World Development Indicators (WDI) that help to monitor the Sustainable Development Goals (SDGs).
RELX SDG Customer Awards aim to recognise RELX customers who share our commitment to driving action in support of the United Nations Sustainable Development Goals. Read more about the 2022 winners.

Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the United States.

Problem: Within maternity care policies and practice, pregnant migrant women are regarded as a vulnerable population.

Elsevier,

Clinical Ophthalmic Genetics and Genomics, 2022, Pages 457-463Gallie

Understanding the genetics of retinoblastoma has enabled clinicians to develop targeted screening guidelines based on genetic risk, minimising unnecessary screening exams, and focusing resources on individuals at greatest risk. The goal of SDG target 3.d is to strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risk.
Graphical abstract
This is a methods paper to quantify HIV reservoir. This high-throughput cross-subtype reservoir assay will be useful in HIV cure research in Africa and Asia, where HIV prevalence is highest.
We explore ethical premises and practical implications of using genetic testing to predict suicide risk.

Pages